Is Eli Lilly (LLY) Still the Undisputed Leader in the $150 Billion Obesity Drug Market?

Reported by Yahoo Finance · Published 4 Aug 2026, 11:15 PM MYT (2 hr ago)

Summary

Source & full coverage: this summary is aggregated from Yahoo Finance, the original publisher. Read the complete report for full context, data and quotes.

Read the original report at Yahoo Finance →

Most Recent

It’s getting easier for terminally ill people to end their own lives. What to know as laws change. 22 min ago Hashdex to Shut Down Bitcoin ETF After Struggling to Gain Assets 34 min ago Markets see 'all hat, no cattle' in Fed's inflation credibility: Chart of the Day 37 min ago Is United Parcel Service (UPS) the Best Dividend Stock in the Industrial Sector? 38 min ago NVIDIA Facing 12-to-1 Demand to Supply for its Chips, Says Expert—and It Might Be Time to Buy 39 min ago Danaher Beat Earnings Estimates, so Why Are Investors Still Concerned About Growth? 43 min ago

EconPulse

Markets. Economy. Malaysia & The World.

Independent economic news aggregation for Malaysia, Asia and global markets, updated throughout the day.

Company

About Us Editorial Standards & Corrections Privacy Policy

Work With Us

Submit a Press Release Partnerships & Advertising Contact Us RSS Feed

Contact

editor@econpulse.my

Editorial & newsroom enquiries answered within 1–2 business days.

Is Eli Lilly (LLY) Still the Undisputed Leader in the $150 Billion Obesity Drug Market?

Summary

More in Markets

It’s getting easier for terminally ill people to end their own lives. What to know as laws change.

Hashdex to Shut Down Bitcoin ETF After Struggling to Gain Assets

Markets see 'all hat, no cattle' in Fed's inflation credibility: Chart of the Day

Is United Parcel Service (UPS) the Best Dividend Stock in the Industrial Sector?

NVIDIA Facing 12-to-1 Demand to Supply for its Chips, Says Expert—and It Might Be Time to Buy

Danaher Beat Earnings Estimates, so Why Are Investors Still Concerned About Growth?